• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to 4-(dimethylamino)piperidine-4-carboxamide dihydrochloride (CAS No. 97392-68-2)

4-(dimethylamino)piperidine-4-carboxamide dihydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 97392-68-2, is a significant compound in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the piperidine class of heterocyclic amines, characterized by a six-membered ring containing one nitrogen atom. The presence of a dimethylamino group at the 4-position and a carboxamide moiety at the 4-position further enhances its structural complexity and potential biological activity. The dihydrochloride salt form improves its solubility in aqueous solutions, making it more suitable for various biochemical and pharmacological applications.

The structure of 4-(dimethylamino)piperidine-4-carboxamide dihydrochloride exhibits unique electronic and steric properties due to the combination of the dimethylamino group and the carboxamide side chain. These features contribute to its interaction with biological targets, such as enzymes and receptors, which is crucial for its pharmacological effects. The compound's ability to modulate these interactions has garnered interest in its potential use as an intermediate in drug synthesis or as a lead compound for further medicinal chemistry exploration.

In recent years, there has been growing interest in piperidine derivatives due to their diverse biological activities. 4-(dimethylamino)piperidine-4-carboxamide dihydrochloride has been studied for its potential role in various therapeutic areas, including central nervous system (CNS) disorders, inflammation, and cancer. Its molecular framework allows for selective binding to specific biological targets, which is essential for developing drugs with high efficacy and low toxicity.

One of the most compelling aspects of 4-(dimethylamino)piperidine-4-carboxamide dihydrochloride is its versatility as a chemical scaffold. Researchers have utilized this compound as a starting point for designing novel molecules with enhanced pharmacological properties. For instance, modifications to the dimethylamino group or the carboxamide moiety can lead to compounds with improved solubility, bioavailability, or target specificity. This adaptability makes it a valuable tool in drug discovery pipelines.

The pharmaceutical industry has increasingly focused on developing small-molecule inhibitors that target enzymes involved in critical biological pathways. 4-(dimethylamino)piperidine-4-carboxamide dihydrochloride has been explored as a potential inhibitor for enzymes such as kinases and proteases, which play key roles in cell signaling and disease progression. Its structural features allow it to mimic natural substrates or interfere with enzyme activity, thereby modulating cellular processes.

Recent studies have highlighted the compound's potential in treating neurological disorders. The piperidine ring's ability to cross the blood-brain barrier makes it an attractive candidate for CNS-targeted therapies. Additionally, the dimethylamino group can enhance penetration into neural tissues, improving therapeutic efficacy. Preclinical studies have shown that derivatives of 4-(dimethylamino)piperidine-4-carboxamide dihydrochloride exhibit promising effects in models of neurodegenerative diseases, such as Alzheimer's and Parkinson's.

Another area of interest is the compound's role in anti-inflammatory applications. Chronic inflammation is associated with numerous diseases, including cardiovascular disorders, diabetes, and autoimmune conditions. By targeting inflammatory pathways, 4-(dimethylamino)piperidine-4-carboxamide dihydrochloride and its derivatives may offer therapeutic benefits. Research has demonstrated that certain piperidine-based compounds can inhibit pro-inflammatory cytokines and enzymes, thereby reducing inflammation and associated symptoms.

The synthesis of 4-(dimethylamino)piperidine-4-carboxamide dihydrochloride involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advanced synthetic techniques, such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to improve efficiency and scalability. The development of robust synthetic routes is essential for large-scale production and commercialization of pharmaceutical intermediates like this compound.

In conclusion, 4-(dimethylamino)piperidine-4-carboxamide dihydrochloride (CAS No. 97392-68-2) represents a significant advancement in pharmaceutical chemistry due to its versatile structure and potential biological activities. Its applications span multiple therapeutic areas, including CNS disorders, inflammation, and cancer treatment. Ongoing research continues to uncover new possibilities for this compound and its derivatives, reinforcing its importance in drug discovery and development.

• 84100-54-9(4-(Ethylamino)piperidine-4-carboxamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)